Imaging Evaluation of Intrathecal Baclofen Pump-Catheter Systems

References

1. 1.↵
   1. Penn RD,
   2. Kroin JS

   . Intrathecal baclofen alleviates spinal cord spasticity. Lancet 1984;1:1078

   PubMedWeb of Science
2. 2.↵
   1. Dralle D,
   2. Muller H,
   3. Zierski J,
   4. et al

   . Intrathecal baclofen for spasticity. Lancet 1985;2:1003

   PubMedWeb of Science
3. 3.↵
   1. Gilmartin R,
   2. Bruce D,
   3. Storrs BB,
   4. et al

   . Intrathecal baclofen for management of spastic cerebral palsy: multicenter trial. J Child Neurol 2000;15:71–77

   Abstract/FREE Full Text
4. 4.↵
   1. Van Schaeybroeck P,
   2. Nuttin B,
   3. Lagae L,
   4. et al

   . Intrathecal baclofen for intractable cerebral spasticity: a prospective placebo-controlled, double-blind study. Neurosurgery 2000;46:603–09, discussion 609–12

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Becker R,
   2. Alberti O,
   3. Bauer BL

   . Continuous intrathecal baclofen infusion in severe spasticity after traumatic or hypoxic brain injury. J Neurol 1997;244:160–66

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Becker R,
   2. Benes L,
   3. Sure U,
   4. et al

   . Intrathecal baclofen alleviates autonomic dysfunction in severe brain injury. J Clin Neurosci 2000;7:316–19

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Penn RD

   . Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg 1992;77:236–40

   PubMedWeb of Science
8. 8.↵
   1. Meythaler JM,
   2. Guin-Renfroe S,
   3. Brunner RC,
   4. et al

   . Intrathecal baclofen for spastic hypertonia from stroke. Stroke 2001;32:2099–109

   Abstract/FREE Full Text
9. 9.↵
   1. Stempien L,
   2. Tsai T

   . Intrathecal baclofen pump use for spasticity: a clinical survey. Am J Phys Med Rehabil 2000;79:536–41

   CrossRefPubMed
10. 10.↵
    1. Guillaume D,
    2. Van Havenbergh A,
    3. Vloeberghs M,
    4. et al

    . A clinical study of intrathecal baclofen using a programmable pump for intractable spasticity. Arch Phys Med Rehabil 2005;86:2165–71

    CrossRefPubMed
11. 11.↵
    1. Albright AL,
    2. Awaad Y,
    3. Muhonen M,
    4. et al

    . Performance and complications associated with the SychroMed 10-ml infusion pump for intrathecal baclofen administration in children. J Neurosurg 2004;101(1 suppl):64–68

    PubMed
12. 12.↵
    1. Albright AL,
    2. Barry MJ,
    3. Fasick P,
    4. et al

    . Continuous intrathecal baclofen infusion for symptomatic generalized dystonia. Neurosurgery 1996;38:934–38, discussion 938–39

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Albright AL,
    2. Barry MJ,
    3. Shafton DH,
    4. et al

    . Intrathecal baclofen for generalized dystonia. Dev Med Child Neurol 2001;43:652–57

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Motta F,
    2. Antonello CE,
    3. Stignani C

    . Upper limbs function after intrathecal baclofen therapy in children with secondary dystonia. J Pediatr Orthop 2009;29:817–21

    CrossRefPubMed
15. 15.↵
    1. Grabb PA,
    2. Guin-Renfroe S,
    3. Meythaler JM

    . Midthoracic catheter tip placement for intrathecal baclofen administration in children with quadriparetic spasticity. Neurosurgery 1999;45:833–36, discussion 836–37

    CrossRefPubMedWeb of Science
16. 16.↵
    1. McCall TD,
    2. MacDonald JD

    . Cervical catheter tip placement for intrathecal baclofen administration. Neurosurgery 2006;59:634–40

    CrossRefPubMed
17. 17.↵
    1. Macdonell RA,
    2. Talalla A,
    3. Swash M,
    4. et al

    . Intrathecal baclofen and the H-reflex. J Neurol Neurosurg Psychiatry 1989;52:1110–12

    Abstract/FREE Full Text
18. 18.↵
    1. Muller H,
    2. Zierski J,
    3. Dralle D,
    4. et al

    . The effect of intrathecal baclofen on electrical muscle activity in spasticity. J Neurol 1987;234:348–52

    CrossRefPubMed
19. 19.↵
    1. Albright AL

    . Intrathecal baclofen in cerebral palsy movement disorders. J Child Neurol 1996;11(suppl 1):S29–35

    Abstract/FREE Full Text
20. 20.↵
    1. Gracies JM,
    2. Nance P,
    3. Elovic E,
    4. et al

    . Traditional pharmacological treatments for spasticity. Part II. General and regional treatments. Muscle Nerve Suppl 1997;6:S92–120

    PubMed
21. 21.↵
    1. Kroin JS,
    2. Ali A,
    3. York M,
    4. et al

    . The distribution of medication along the spinal canal after chronic intrathecal administration. Neurosurgery 1993;33:226–30, discussion 230

    PubMedWeb of Science
22. 22.↵
    1. Brennan PM,
    2. Whittle IR

    . Intrathecal baclofen therapy for neurological disorders: a sound knowledge base but many challenges remain. Br J Neurosurg 2008;22:508–19

    CrossRefPubMed
23. 23.↵
    1. Albright AL,
    2. Turner M,
    3. Pattisapu JV

    . Best-practice surgical techniques for intrathecal baclofen therapy. J Neurosurg 2006;104(4 suppl):233–39

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Vender JR,
    2. Hester S,
    3. Waller JL,
    4. et al

    . Identification and management of intrathecal baclofen pump complications: a comparison of pediatric and adult patients. J Neurosurg 2006;104(1 suppl):9–15

    PubMed
25. 25.↵
    1. Kao LW,
    2. Amin Y,
    3. Kirk MA,
    4. et al

    . Intrathecal baclofen withdrawal mimicking sepsis. J Emerg Med 2003;24:423–27

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Dawes WJ,
    2. Drake JM,
    3. Fehlings D

    . Microfracture of a baclofen pump catheter with intermittent under- and overdose. Pediatr Neurosurg 2003;39:144–48

    CrossRefPubMed
27. 27.↵
    1. Alden TD,
    2. Lytle RA,
    3. Park TS,
    4. et al

    . Intrathecal baclofen withdrawal: a case report and review of the literature. Childs Nerv Syst 2002;18:522–25. Epub 2002 Jul 23

    CrossRefPubMed
28. 28.↵
    1. Plassat R,
    2. Perrouin Verbe B,
    3. et al

    . Treatment of spasticity with intrathecal baclofen administration: long-term follow-up, review of 40 patients. Spinal Cord 2004;42:686–93

    CrossRefPubMed
29. 29.↵
    1. Coffey JR,
    2. Cahill D,
    3. Steers W,
    4. et al

    . Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg 1993;78:226–32

    PubMedWeb of Science
30. 30.↵
    1. Gooch JL,
    2. Oberg WA,
    3. Grams B,
    4. et al

    . Complications of intrathecal baclofen pumps in children. Pediatr Neurosurg 2003;39:1–6

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Fluckiger B,
    2. Knecht H,
    3. Grossmann S,
    4. et al

    . Device-related complications of long-term intrathecal drug therapy via implanted pumps. Spinal Cord 2008;46:639–43

    CrossRefPubMedWeb of Science
32. 32.↵
    1. Albright AL,
    2. Gilmartin R,
    3. Swift D,
    4. et al

    . Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin. J Neurosurg 2003;98:291–95

    PubMedWeb of Science
33. 33.↵
    1. Bardutzky J,
    2. Tronnier V,
    3. Schwab S,
    4. et al

    . Intrathecal baclofen for stiff-person syndrome: life-threatening intermittent catheter leakage. Neurology 2003;60:1976–78

    Abstract/FREE Full Text
34. 34.↵
    1. Francisco GE,
    2. Saulino MF,
    3. Yablon SA,
    4. et al

    . Intrathecal baclofen therapy: an update. PM R 2009;1:852–58

    PubMed
35. 35.↵
    1. Motta F,
    2. Buonaguro V,
    3. Stignani C

    . The use of intrathecal baclofen pump implants in children and adolescents: safety and complications in 200 consecutive cases. J Neurosurg 2007;107(1 suppl):32–35

    PubMed
36. 36.↵
    1. Shirley KW,
    2. Kothare S,
    3. Piatt JH Jr.,
    4. et al

    . Intrathecal baclofen overdose and withdrawal. Pediatr Emerg Care 2006;22:258–61

    CrossRefPubMed
37. 37.↵
    1. Le Breton F,
    2. Daviet JC,
    3. Monteil J,
    4. et al

    . Radioisotopic control for baclofen pump catheter failure. Spinal Cord 2001;39:283–85

    CrossRefPubMed
38. 38.↵
    1. Pak S,
    2. Jallo GI,
    3. Biser A,
    4. et al

    . Indium-111 diethylene-triamine-pentaacetic acid scintigraphy in the evaluation of function and patency of baclofen intrathecal infusion systems. Neurosurg Focus, 2007;23:E17

    PubMed
39. 39.↵
    1. Yeh RN,
    2. Nypaver MM,
    3. Deegan TJ,
    4. et al

    . Baclofen toxicity in an 8-year-old with an intrathecal baclofen pump. J Emerg Med 2004;26:163–67

    CrossRefPubMed
40. 40.↵
    1. Li TC,
    2. Chen MH,
    3. Huang JS,
    4. et al

    . Catheter migration after implantation of an intrathecal baclofen infusion pump for severe spasticity: a case report. Kaohsiung J Med Sci 2008;24:492–97

    CrossRefPubMed
41. 41.↵
    1. Pasquier Y,
    2. Cahana A,
    3. Schnider A

    . Subdural catheter migration may lead to baclofen pump dysfunction. Spinal Cord 2003;41:700–02

    CrossRefPubMed
42. 42.↵
    1. Rosenson AS,
    2. Ali A,
    3. Fordham EW,
    4. et al

    . Indium-111 DTPA flow study to evaluate surgically implanted drug pump delivery system. Clin Nucl Med 1990;15:154–56

    CrossRefPubMed
43. 43.↵
    1. Stinchon JF,
    2. Shah NP,
    3. Ordia J,
    4. et al

    . Scintigraphic evaluation of intrathecal infusion systems: selection of patients for surgical or medical management. Clin Nucl Med 2006;3:1–4
44. 44.↵
    1. O'Connell M,
    2. Wong TZ,
    3. Forkheim KE,
    4. et al

    . Comparison of Tc99m-DTPA and indium-111 DTPA studies of baclofen pump function. Clin Nucl Med 2004;29:578–80

    CrossRefPubMed
45. 45.↵
    1. Deer TR,
    2. Raso LJ,
    3. Garten TG

    . Inflammatory mass of an intrathecal catheter in patients receiving baclofen as a sole agent: a report of two cases and a review of the identification and treatment of the complication. Pain Med 2007;8:259–62

    CrossRefPubMed